Atlas Trials

Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

Clinical trial NCT00557830 · TERMINATED

Trial details

NCT number
NCT00557830
Sponsor
Accelerated Community Oncology Research Network
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal Cell Carcinoma
Start date
2008-01-01
Primary completion
2011-04-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.